Szymczak, Maciej http://orcid.org/0000-0002-1248-081X
Heidecke, Harald
Żabińska, Marcelina
Rukasz, Dagna
Wiśnicki, Krzysztof
Tukiendorf, Andrzej
Krajewska, Magdalena
Banasik, Mirosław
Funding for this research was provided by:
Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu (Grant for Young Investigators nr STM. C160.20.080.)
Article History
Received: 16 May 2022
Accepted: 31 August 2022
First Online: 24 September 2022
Declarations.
:
: All authors declare no conflict of interest. Blood analysis was performed by CELLTREND (Luckenwalde, Germany) free of charge. Maciej Szymczak, Marcelina Żabińska, Dagna Rukasz, Krzysztof Grubizna, Magdalena Krajewska, Mirosław Banasik have nothing to disclose. Harald Heidecke is CEO and stakeholder of Celltrend GmbH.